(18.97.14.86)
[ij] [ij] [ij] 
Email id
 

Research Journal of Pharmacy and Technology
Year : 2018, Volume : 11, Issue : 2
First page : ( 677) Last page : ( 680)
Print ISSN : 0974-3618. Online ISSN : 0974-360X.
Article DOI : 10.5958/0974-360X.2018.00127.0

A Study on Socio Demographic and Associated Risk Factors for Cancer Patients in Private Cancer Hospital, Bangalore, India

Krishnaveni K1,*, Jose Rosmi2, Sumitha SK2, Johny Teena2, Sundaram Shanmuga R3, Sambathkumar R4

1Assistant Professor, Department of Pharmacy Practice, J.K.K. Nattraja College of Pharmacy, Kumarapalayam, Tamilnadu-638183, India

2Post Graduates, Department of Pharmacy Practice, J.K.K. Nattraja College of Pharmacy, Kumarapalayam, Tamilnadu-638183, India

3Professor, Department of Pharmacology, J.K.K. Nattraja College of Pharmacy, Kumarapalayam, Tamilnadu-638183, India

4Professor, Department of Pharmaceutics, J.K.K. Nattraja College of Pharmacy, Kumarapalayam, Tamilnadu-638183, India

*Corresponding Author E-mail: venidhiya@gmail.com

Online published on 12 June, 2018.

Abstract

A prospective observational study was carried out in an oncology department of a tertiary care hospital, to evaluate the sociodemographics and risk factors of cancer over a period of 6 months. A total of 120 cancer patients participated in the study. Out of 120 cancer patients, 50 were male and 70 were female. Most of the patients were found to be in the age group of 60–70 years (36%) in males and 40–50 years (26%) in females. The most common cancer was found to be breast cancer(23.3%) followed by cervix (10.83%) lung (8.3%), uterus (6.6%), bladder and tongue (4.16%), throat (3%), bone(1.6%), esophagus and endometrium (3.33%), acute leukemia, brain, buccal mucosa, colorectal, colon, fallopian tube, intestine and ovary (0.83%). The prescribed drugs for cancer patients were avastatin (28%), fluorouracil (26%), dexamethasone (66%), bondronate (18%), nerdoxa (14%), anticoagulant-heparin (84%), antiulcer drugs-pantoprazole (100%), anesthesia (44%), and antineoplastic-neomycin (38%) in male patients. The recommended anticancer drugs for female patients were avastatin (31.42%), fluorouracil (21.42%), dexamethasone (15.71%), bondronate (14.2%), nerdoxa (41.4%), anticoagulant-heparin (70%), antiulcer drugs-pantoprazole (100%), anesthesia (22.8%), and antineoplastic-bleomycin (32.8%). The study concluded that there is a need for public awareness programmes about the cancer and its risk factors, early detection, prevention and its management.

Top

Keywords

Cancer, breast cancer, cervical cancer, anticancer drugs.

Top

  
║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
835,704,884 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.